BioSpace News Archive

Drug Development

AIM ImmunoTech Announces Phase 2 Study of Ampligen® for the Treatment of Pancreatic Cancer is Open and Recruiting Patients

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the AMP-270 Phase 2 study of Ampligen as a therapy for locally advanced pancreatic cancer (“LAPC”) has opened its first clinical site and has begun recruiting patients.

February 28, 2023

·

3 min read

NanoSpot.ai Brings AI-driven Antibody Testing to the Masses with the Launch of its SARS-CoV-2 Test

NanoSpot.ai, a biotechnology diagnostics company, announces the full commercial release of its SARS-CoV-2 Total Antibody Test.

February 28, 2023

·

2 min read

Biotech Beach

Evolus to Participate in the Barclays Global Healthcare Conference - February 28, 2023

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida.

February 28, 2023

·

1 min read

Business

Promore Pharma: Year-End Report, 2022

In January 2022, warrants corresponding to a dilution of 0.2% of the number of outstanding shares were deregistered.

February 28, 2023

·

2 min read

Genetown

Spero Therapeutics to Present at Upcoming March 2023 Investor Conferences

Spero Therapeutics, Inc. announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the Cowen 43rd Annual Healthcare Conference.

February 28, 2023

·

4 min read

Business

Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced the appointment of Jennifer Kamocsay as General Counsel.

February 28, 2023

·

2 min read

Business

Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer

Sutro Biopharma, Inc. today announced the appointment of Anne Borgman, M.D., as Chief Medical Officer, effective February 28, 2023.

February 28, 2023

·

6 min read

Business

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today reported financial results for the fourth quarter and full year ended December 31, 2022, and provided a business update.

February 28, 2023

·

10 min read

Genetown

Ocular Therapeutix™ to Present at Cowen’s 43rd Annual Healthcare Conference

Ocular Therapeutix, Inc. today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will participate in a fireside chat at Cowen’s 43rd Annual Healthcare Conference on Tuesday, March 7, 2023 at 1:30 PM EST.

February 28, 2023

·

1 min read

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a pipeline of immune-modulating assets designed to target a spectrum of cardiovascular and autoimmune diseases, today reported fourth quarter and full-year 2022 financial results and recent portfolio execution.

February 28, 2023

·

14 min read